Medicure Inc. filings document a Canadian foreign private issuer that furnishes Form 6-K reports to the SEC while operating a U.S.-focused pharmaceutical and healthcare products business. The filings include press releases, management discussion and analysis, and condensed consolidated interim financial statements related to Medicure Pharma, AGGRASTAT, ZYPITAMAG, pharmacy operations, and research and development activity.
The company’s regulatory reports also provide formal disclosure of periodic operating results, product and pharmacy revenue categories, governance matters, and current corporate events. As a Form 20-F filer, Medicure’s SEC record centers on furnished foreign-issuer reports under Exchange Act Rule 13a-16 or 15d-16.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.79%
Tags
FAQ
How many MEDICURE (MCUJF) SEC filings are available on StockTitan?
StockTitan tracks 11 SEC filings for MEDICURE (MCUJF), including 20-F annual reports and 6-K reports. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.
When was the most recent SEC filing for MEDICURE (MCUJF)?
The most recent SEC filing for MEDICURE (MCUJF) was filed on November 14, 2025.